Ramona Doyle
Chief Executive Officer at The MAVEN Project
Ramona Doyle active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The MAVEN Project | Chief Executive Officer | 31/08/2020 | - |
| The University of California, San Francisco | Corporate Officer/Principal | 30/09/2011 | - |
Career history of Ramona Doyle
Former positions of Ramona Doyle
| Companies | Position | Start | End |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/11/2020 | 06/06/2022 |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 31/12/2016 | 30/04/2018 |
| California Institute for Regenerative Medicine | Corporate Officer/Principal | 30/06/2015 | 30/06/2016 |
| Stanford University School of Medicine | Corporate Officer/Principal | 31/12/1994 | 31/12/2007 |
Training of Ramona Doyle
| Sewanee-The University of the South | Undergraduate Degree |
| University of Oxford | Graduate Degree |
| Emory University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| The MAVEN Project | |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Commercial Services |
| California Institute for Regenerative Medicine | Government |
- Stock Market
- Insiders
- Ramona Doyle
- Experience
